Patent
Synthetic cannabinoid combination therapy compositions and methods for personalized and targeted therapies including the treatment of infectious diseases (US Patent 11554184)
Vyripharm Enterprises, Inc. · Granted Jan 17, 2023 · Filed Mar 17, 2022
Patent number: 11554184 Kind code: B2 Granted: 2023-01-17 Filed: 2022-03-17 Inventors: Jerry L. Bryant, Jr. (Bellaire, TX, US) Assignees: Vyripharm Enterprises, Inc. (Houston, TX, US) CPC: A61K 51/0497
Abstract
Compositions and methods for the personalized and targeted therapeutic treatment of diseases and disorders, including the treatment of pain, inflammation, and infectious diseases in a subject. In
Showing a preview — retrieve the full document via the Exa API.
Powered by the Exa API